TECX — Tectonic Therapeutic, Inc.
—
Nasdaq ·
Health Care ·
Biotechnology ·
CIK 1681087 ·
Last close
$23.33
Market Cap
$456.09M
52W High
$39.53
52W Low
$15.45
ADV30
245,963
Next earnings
2026-11-05
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 0 | — | -24,218,000 | -22,285,000 | 237,034,000 | 227,068,000 | 13,188,000 |
| Mar 2026 | 0 | — | -27,301,000 | -25,241,000 | 246,577,000 | 236,894,000 | 16,160,000 |
| Dec 2025 | 0 | — | -21,516,000 | -19,226,000 | 261,038,000 | 253,798,000 | 9,709,000 |
| Sep 2025 | 0 | — | -21,890,000 | -19,035,000 | 277,001,000 | 268,435,000 | 9,473,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-72,140,000
Investing CF
$-244,000
Financing CF
$11,931,000
CapEx
$-306,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-4.57
As of
2026-08-09
Balance + Analyst (yfinance extras)
Retained Earnings
$-270,263,000
Inventory
—
Receivables
—
ST Investments
—
EBIT TTM
$-85,416,000
Pretax Income TTM
$-85,456,000
Interest Exp TTM
$40,000
Analysts
9
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 0 | -84,036,000 | -74,151,000 | 261,038,000 | 9,709,000 | 251,329,000 | -60,078,000 |
| Dec 2024 | 0 | -58,015,000 | -57,982,000 | 152,905,000 | 12,129,000 | 140,776,000 | -59,080,000 |
| Dec 2023 | 0 | -44,648,000 | -42,823,000 | 39,399,000 | 124,035,000 | -84,636,000 | -40,681,000 |
| Dec 2022 | 0 | -32,830,000 | -32,180,000 | 47,209,000 | 92,863,000 | -45,654,000 | -27,637,000 |
TTM Snapshot
Revenues TTM
$11,034,000
NetIncome TTM
$-83,486,000
OpCashFlow TTM
—
Assets (Latest)
$246,577,000
Forward EPS
$-4.68
Max Pain — expiry 2026-12-18
max pain strike: $30.00 · spot: $23.33 · call oi: 1,408 · put oi: 1,363
Expected Move to 2026-12-18:
±$15.60
(66.87%) —
implied range
$7.73 –
$38.93
· ATM straddle on $22.50 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| ENTX | Entera Bio Ltd. | $460.56M | $2.66 | — |
| AGMB | AgomAb Therapeutics NV | $447.17M | $9.08 | — |
| EDIT | Editas Medicine, Inc. | $445.38M | $2.90 | — |
| AUTL | Autolus Therapeutics plc | $481.75M | $1.81 | — |
| ALLO | Allogene Therapeutics, Inc. | $504.42M | $1.46 | — |
News headlines (Yahoo Finance, 1h cache)
Tectonic Therapeutic (TECX) Clears Two Trial Hurdles With Cash To Spare
2026-09-10 04:55 · Yahoo
Tectonic Therapeutic Announces First Quarter 2026 Financial Results and Recent Business Highlights
2026-05-07 20:01 · Yahoo
Tectonic Therapeutic Appoints Jessica Chutter to Board of Directors
2026-04-23 20:01 · Yahoo
Tectonic Therapeutic (NASDAQ:TECX) Is In A Good Position To Deliver On Growth Plans
2026-05-01 14:24 · Yahoo
Tectonic Therapeutic Announces Favorable Phase 1 Safety, Tolerability and PK Results for TX2100, a Novel Approach for the Treatment of Hereditary Hemorrhagic Telangiectasia (HHT)
2026-09-29 12:00 · Yahoo
Tectonic Therapeutic Announces Second Quarter 2026 Financial Results and Recent Business Highlights
2026-08-06 20:01 · Yahoo
TD Asset Management Inc. Announces TD ETF Distributions
2026-06-17 12:30 · Yahoo
Tectonic Therapeutic Completes Enrollment in TX45 APEX Phase 2 Clinical Trial in PH-HFpEF Patients
2026-06-10 20:01 · Yahoo
Tectonic Therapeutic to Participate in March Investor Conferences
2026-03-02 13:00 · Yahoo
Tectonic Therapeutic Announces Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights
2026-02-26 21:17 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.